Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Archives Internationales De Pharmacodynamie Et De Therapie
|
November 1, 1986
In vitro vasorelaxing activity of suloctidil
P Calderon, W van Dorsser, K Geöcze von Szendroi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 4, 1999
In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent
J M Nicolas, P Collart, B Gerin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1987
Smooth muscle relaxing, acute and long-term blood pressure lowering effects of atriopeptins. Structure-activity relationship
J G De Mey, C Cuthbert, K G von Szendroi, et al.
Archives of Toxicology
|
January 1, 1997
Observation of hepatotoxic effects of 2-n-pentylaminoacetamide (Milacemide) in rat liver by a combined in vivo/in vitro approach
V Rogiers, Y Vandenberghe, T Vanhaecke, et al.
European Journal of Pharmacology
|
September 30, 1983
The adenylate cyclase activity in heart membranes from normotensive and spontaneously hypertensive rats, after chemical sympathectomy, suggests the presence of presynaptic secretin receptors
P Chatelain, P Robberecht, J C Camus, et al.
European Journal of Pharmacology
|
June 10, 1981
Comparative effects of alpha-methyldopa, propranolol and hydralazine therapy on cardiac adenylate cyclase activity in normal and spontaneously hypertensive rats
P Chatelain, M Waelbroeck, J C Camus, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 1, 1994
Comparative metabolism of SC-42867 and SC-51089, two PGE2 antagonists, in rat and human hepatocyte cultures
K Lee, Y Vandenberghe, M Herin, et al.
Journal of Neurochemistry
|
October 1, 1989
The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B
P Janssens de Varebeke, G Pauwels, C Buyse, et al.
Pflugers Archiv : European Journal of Physiology
|
April 1, 1983
Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the heart of five animal species
P Chatelain, P Robberecht, M Waelbroeck, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Archives Internationales De Pharmacodynamie Et De Therapie
|
November 1, 1986
In vitro vasorelaxing activity of suloctidil
P Calderon, W van Dorsser, K Geöcze von Szendroi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 4, 1999
In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent
J M Nicolas, P Collart, B Gerin, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 1987
Smooth muscle relaxing, acute and long-term blood pressure lowering effects of atriopeptins. Structure-activity relationship
J G De Mey, C Cuthbert, K G von Szendroi, et al.
Archives of Toxicology
|
January 1, 1997
Observation of hepatotoxic effects of 2-n-pentylaminoacetamide (Milacemide) in rat liver by a combined in vivo/in vitro approach
V Rogiers, Y Vandenberghe, T Vanhaecke, et al.
European Journal of Pharmacology
|
September 30, 1983
The adenylate cyclase activity in heart membranes from normotensive and spontaneously hypertensive rats, after chemical sympathectomy, suggests the presence of presynaptic secretin receptors
P Chatelain, P Robberecht, J C Camus, et al.
European Journal of Pharmacology
|
June 10, 1981
Comparative effects of alpha-methyldopa, propranolol and hydralazine therapy on cardiac adenylate cyclase activity in normal and spontaneously hypertensive rats
P Chatelain, M Waelbroeck, J C Camus, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 1, 1994
Comparative metabolism of SC-42867 and SC-51089, two PGE2 antagonists, in rat and human hepatocyte cultures
K Lee, Y Vandenberghe, M Herin, et al.
Journal of Neurochemistry
|
October 1, 1989
The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B
P Janssens de Varebeke, G Pauwels, C Buyse, et al.
Pflugers Archiv : European Journal of Physiology
|
April 1, 1983
Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the heart of five animal species
P Chatelain, P Robberecht, M Waelbroeck, et al.
Page
of 5